RapidAIM: a culture- and metaproteomics-based Rapid Assay of Individual Microbiome responses to drugs
2020 · Microbiome · 325 citations
https://doi.org/10.1186/s40168-020-00806-z
K
Kai Cheng
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
205
Papers
6.5K
Citations
42
h-index
110
i10-index
Kai Cheng is an academic researcher from University of Ottawa. The author has contributed to research in topics: Advanced Proteomics Techniques and Applications & Glycosylation and Glycoproteins Research & Gut microbiota and health. The author has an h-index of 42, co-authored 175 publications.
ORCID: 0000-0002-6045-0244Papers by this author
worksGlobal Screening of CK2 Kinase Substrates by an Integrated Phosphoproteomics Workflow
2013 · Scientific Reports · 153 citations
https://doi.org/10.1038/srep03460
Community evaluation of glycoproteomics informatics solutions reveals high-performance search strategies for serum glycopeptide analysis
2021 · Nature Methods · 144 citations
https://doi.org/10.1038/s41592-021-01309-x
A national-scale assessment of land subsidence in China’s major cities
2024 · Science · 133 citations
https://doi.org/10.1126/science.adl4366
SF3B4 is regulated by microRNA-133b and promotes cell proliferation and metastasis in hepatocellular carcinoma
2018 · EBioMedicine · 58 citations
https://doi.org/10.1016/j.ebiom.2018.10.067
Methylation Status of the <i>Nanog</i> Promoter Determines the Switch between Cancer Cells and Cancer Stem Cells
2020 · Advanced Science · 43 citations
https://doi.org/10.1002/advs.201903035
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat